These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

293 related articles for article (PubMed ID: 20645082)

  • 1. Lactococcal membrane-permeabilizing antimicrobial peptides.
    Zendo T; Yoneyama F; Sonomoto K
    Appl Microbiol Biotechnol; 2010 Sep; 88(1):1-9. PubMed ID: 20645082
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lacticin Q, a lactococcal bacteriocin, causes high-level membrane permeability in the absence of specific receptors.
    Yoneyama F; Imura Y; Ichimasa S; Fujita K; Zendo T; Nakayama J; Matsuzaki K; Sonomoto K
    Appl Environ Microbiol; 2009 Jan; 75(2):538-41. PubMed ID: 19011053
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sequential actions of the two component peptides of the lantibiotic lacticin 3147 explain its antimicrobial activity at nanomolar concentrations.
    Morgan SM; O'connor PM; Cotter PD; Ross RP; Hill C
    Antimicrob Agents Chemother; 2005 Jul; 49(7):2606-11. PubMed ID: 15980326
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Class II antimicrobial peptides from lactic acid bacteria.
    Nes IF; Holo H
    Biopolymers; 2000; 55(1):50-61. PubMed ID: 10931441
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Permeabilization and lysis induced by bacteriocins and its effect on aldehyde formation by Lactococcus lactis.
    Martínez-Cuesta MC; Requena T; Peláez C
    Biotechnol Lett; 2006 Oct; 28(19):1573-80. PubMed ID: 16900333
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nisin and lacticin 481 coproduction by Lactococcus lactis strains isolated from raw ewes' milk.
    Bravo D; Rodríguez E; Medina M
    J Dairy Sci; 2009 Oct; 92(10):4805-11. PubMed ID: 19762795
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bacteriocin-based strategies for food biopreservation.
    Gálvez A; Abriouel H; López RL; Ben Omar N
    Int J Food Microbiol; 2007 Nov; 120(1-2):51-70. PubMed ID: 17614151
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Developing applications for lactococcal bacteriocins.
    Ross RP; Galvin M; McAuliffe O; Morgan SM; Ryan MP; Twomey DP; Meaney WJ; Hill C
    Antonie Van Leeuwenhoek; 1999; 76(1-4):337-46. PubMed ID: 10532388
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diversity and applications of Bacillus bacteriocins.
    Abriouel H; Franz CM; Ben Omar N; Gálvez A
    FEMS Microbiol Rev; 2011 Jan; 35(1):201-32. PubMed ID: 20695901
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antimicrobial mechanism of lantibiotics.
    Islam MR; Nagao J; Zendo T; Sonomoto K
    Biochem Soc Trans; 2012 Dec; 40(6):1528-33. PubMed ID: 23176511
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pediocin-like antimicrobial peptides (class IIa bacteriocins) and their immunity proteins: biosynthesis, structure, and mode of action.
    Fimland G; Johnsen L; Dalhus B; Nissen-Meyer J
    J Pept Sci; 2005 Nov; 11(11):688-96. PubMed ID: 16059970
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lactococcal bacteriocins: mode of action and immunity.
    Venema K; Venema G; Kok J
    Trends Microbiol; 1995 Aug; 3(8):299-304. PubMed ID: 8528613
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The biology of lantibiotics from the lacticin 481 group is coming of age.
    Dufour A; Hindré T; Haras D; Le Pennec JP
    FEMS Microbiol Rev; 2007 Mar; 31(2):134-67. PubMed ID: 17096664
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Posttranslationally modified bacteriocins--the lantibiotics.
    Guder A; Wiedemann I; Sahl HG
    Biopolymers; 2000; 55(1):62-73. PubMed ID: 10931442
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biosynthetic characterization and biochemical features of the third natural nisin variant, nisin Q, produced by Lactococcus lactis 61-14.
    Yoneyama F; Fukao M; Zendo T; Nakayama J; Sonomoto K
    J Appl Microbiol; 2008 Dec; 105(6):1982-90. PubMed ID: 19120645
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Screening and characterization of novel bacteriocins from lactic acid bacteria.
    Zendo T
    Biosci Biotechnol Biochem; 2013; 77(5):893-9. PubMed ID: 23649268
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bioengineering of the model lantibiotic nisin.
    Field D; Cotter PD; Ross RP; Hill C
    Bioengineered; 2015; 6(4):187-92. PubMed ID: 25970137
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ribosomally synthesized antimicrobial peptides: their function, structure, biogenesis, and mechanism of action.
    Nissen-Meyer J; Nes IF
    Arch Microbiol; 1997; 167(2-3):67-77. PubMed ID: 9133328
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The two-peptide class II bacteriocins: structure, production, and mode of action.
    Oppegård C; Rogne P; Emanuelsen L; Kristiansen PE; Fimland G; Nissen-Meyer J
    J Mol Microbiol Biotechnol; 2007; 13(4):210-9. PubMed ID: 17827971
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization and antimicrobial spectrum of bacteriocins produced by lactic acid bacteria isolated from traditional Bulgarian dairy products.
    Simova ED; Beshkova DB; Dimitrov ZhP
    J Appl Microbiol; 2009 Feb; 106(2):692-701. PubMed ID: 19200334
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.